Table 5.
Risk of poor health-related quality of life (HRQoL), assessed with the European Organisation for Research and Treatment of Cancer QLQ-C30, among participants with cardiovascular disease reporting major burden of disease, compared with people reporting minor burden, presented as OR with 95% CI
| Burden of any cardiovascular disease* |
||||
|---|---|---|---|---|
| Minor burden 1166 (86%) |
Major burden 192 (14%) |
|||
| HRQoL aspects† | Number (%) | OR (95% CI)‡ | Number (%) | OR (95% CI)‡ |
| Poor global quality of life | 171 (15) | 1.00 (reference) | 80 (42) | 2.09 (1.21 to 3.60) |
| Poor physical function | 515 (44) | 1.00 (reference) | 160 (83) | 6.18 (3.72 to 10.30) |
| Poor role function | 133 (11) | 1.00 (reference) | 76 (40) | 2.06 (0.95 to 4.49) |
| Poor emotional function | 174 (15) | 1.00 (reference) | 77 (40) | 2.78 (1.55 to 4.98) |
| Symptomatic fatigue | 226 (19) | 1.00 (reference) | 118 (61) | 4.64 (2.73 to 7.88) |
| Symptomatic dyspnoea | 481 (41) | 1.00 (reference) | 149 (78) | 4.37 (2.54 to 7.49) |
Frequency weighted for age and sex to match the national distribution in Sweden.
*Minor burden: Participants reporting ‘none’ or ‘a little’ burden of any cardiovascular disease. Others are grouped as ‘major burden’. Cardiovascular disease: Angina, atrial fibrillation, heart failure, hypertension or earlier myocardial infarction. Participants with multiple diagnosis (255).
†Poor or symptomatic: At least one response of ‘quite a bit’ or ‘very much’ on an item within a scale (physical, role and emotional function, fatigue and dyspnoea) or at least one response of 1-4 on one of the items in the global quality-of-life scale.
‡Adjusted for age, sex, education, comorbidity, tobacco smoking and physical activity.